Inicio / Gastroenterología / Abstracts de gastroenterología / Global prevalence, treatment,…

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

0 / 5 (0 votos)
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

The Lancet Gastroenterology & Hepatology

Fecha de publicación: 26 March 2018

DOI: https://doi.org/10.1016/S2468-1253(18)30056-6

Autores: The Polaris Observatory Collaborators

Background: The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis B virus (HBV) infection, existing therapies to control viral replication and prophylaxis to minimise mother-to-child transmission make elimination of HBV feasible. We aimed to estimate the national, regional, and global prevalence of HBsAg in the general population and in the population aged 5 years in 2016, as well as coverage of prophylaxis, diagnosis, and treatment.

SEGUIR LEYENDO

Comentarios

Para dejar un comentario antes debes iniciar sesión:

¿No tienes una cuenta?

Regístrate a través de éste enlace.